Paper Details

  1. Home
  2. Paper Details

Woringer-Kolopp (Pagetoid Reticulosis) disease successful response to bexarotene gel.

Author: GroysmanVlada, LedetJohnathan, SamiNaveed

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Case ReportsIn the medical field, a report that describes in detail a unique case, an unusual medical condition, or the effect of a treatment. Provides new insights and possibilities for treatment through individual patient cases.

Overview

This report describes three cases of Woringer-Kolopp (WK), a rare subtype of cutaneous T-cell lymphoma, that responded effectively to bexarotene 1% gel.
Paper Details　
Original Abstract of the Article :
Woringer-Kolopp (WK) is a rare subtype of cutaneous T-cell lymphoma (CTCL) with limited treatment options. Bexarotene gel is a topical retinoid used in the treatment of CTCL. This report describes three female patients (mean age 66 years) with WK disease who had an effective treatment response to be...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1111/dth.12281

データ提供：米国国立医学図書館（NLM）

Woringer-Kolopp (Pagetoid Reticulosis) Disease Successful Response to Bexarotene Gel

Woringer-Kolopp (WK) disease, a rare form of cutaneous T-cell lymphoma (CTCL), is like a stubborn desert sandstorm, difficult to control. This report describes three cases of patients with WK disease who experienced successful treatment responses to bexarotene gel, a topical retinoid. The researchers highlight the limited treatment options for WK disease and present bexarotene gel as a potentially safe and effective alternative to other treatment modalities that may have higher risks of adverse effects.

Finding an Oasis in the Desert of CTCL: Exploring Bexarotene Gel

This report provides a glimmer of hope for individuals with WK disease, suggesting that bexarotene gel may offer a valuable treatment option. Further research is needed to confirm its efficacy and long-term safety.

Living with CTCL: A Journey of Hope and Resilience

CTCL is a challenging disease that requires ongoing management and support. It's essential to work closely with your healthcare provider to develop a personalized treatment plan that meets your unique needs.

Dr. Camel's Conclusion

This report suggests that bexarotene gel may be an effective treatment option for Woringer-Kolopp disease. Further research is needed to confirm its efficacy and long-term safety.

Date :
  1. Date Completed 2017-01-10
  2. Date Revised 2018-12-02
Further Info :

Pubmed ID

26332008

DOI: Digital Object Identifier

10.1111/dth.12281

Related Literature

Article Analysis
・Effects of bexarotene topical
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.